FR2705569B1 - Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale. - Google Patents

Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.

Info

Publication number
FR2705569B1
FR2705569B1 FR9406252A FR9406252A FR2705569B1 FR 2705569 B1 FR2705569 B1 FR 2705569B1 FR 9406252 A FR9406252 A FR 9406252A FR 9406252 A FR9406252 A FR 9406252A FR 2705569 B1 FR2705569 B1 FR 2705569B1
Authority
FR
France
Prior art keywords
imidazolylcarbazolone
intended
pharmaceutical composition
rectal administration
composition based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9406252A
Other languages
English (en)
Other versions
FR2705569A1 (fr
Inventor
Thielemans Isabelle
Richard Isabelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoires Glaxo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA filed Critical Laboratoires Glaxo SA
Publication of FR2705569A1 publication Critical patent/FR2705569A1/fr
Application granted granted Critical
Publication of FR2705569B1 publication Critical patent/FR2705569B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FR9406252A 1993-05-25 1994-05-24 Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale. Expired - Lifetime FR2705569B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (2)

Publication Number Publication Date
FR2705569A1 FR2705569A1 (fr) 1994-12-02
FR2705569B1 true FR2705569B1 (fr) 1995-11-10

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9406252A Expired - Lifetime FR2705569B1 (fr) 1993-05-25 1994-05-24 Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.

Country Status (38)

Country Link
US (1) US5741806A (fr)
EP (1) EP0700290B1 (fr)
JP (1) JP2965703B2 (fr)
KR (1) KR100297212B1 (fr)
CN (1) CN1106194C (fr)
AP (1) AP544A (fr)
AT (1) ATE183643T1 (fr)
AU (1) AU680918B2 (fr)
BE (1) BE1007158A3 (fr)
BR (1) BR1100046A (fr)
CA (1) CA2162919C (fr)
CO (1) CO4230094A1 (fr)
CY (1) CY2411B1 (fr)
CZ (1) CZ291041B6 (fr)
DE (1) DE69420266T2 (fr)
DK (1) DK0700290T3 (fr)
EC (1) ECSP941088A (fr)
ES (1) ES2136198T3 (fr)
FR (1) FR2705569B1 (fr)
GB (2) GB9310756D0 (fr)
GR (1) GR3031669T3 (fr)
HR (2) HRP940315B1 (fr)
HU (1) HU227121B1 (fr)
IE (1) IE80632B1 (fr)
IL (1) IL109749A (fr)
IS (1) IS1868B (fr)
IT (1) IT1272990B (fr)
MY (1) MY111445A (fr)
NO (1) NO306448B1 (fr)
NZ (1) NZ267415A (fr)
PE (1) PE13395A1 (fr)
PL (1) PL175578B1 (fr)
RU (1) RU2132684C1 (fr)
SA (1) SA94150003B1 (fr)
SG (1) SG48119A1 (fr)
SI (1) SI0700290T1 (fr)
WO (1) WO1994027599A1 (fr)
ZA (1) ZA943593B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060020739A (ko) * 1998-06-15 2006-03-06 세프라코 아이엔시. 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (-)-노르씨사프라이드의 용도
EP1468685A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (+) optiquement pur
EP1464333A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (-) optiquement pur
NZ508824A (en) * 1998-06-15 2003-10-31 Sepracor Inc Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
EP1311269B1 (fr) * 2000-08-04 2012-02-29 DMI Biosciences, Inc. Methode d'utilisation de dicetopiperazines et composition contenant ces substances

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO164025C (no) * 1984-01-25 1990-08-22 Glaxo Group Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
ITRM940322A0 (it) 1994-05-24
PE13395A1 (es) 1995-05-25
IT1272990B (it) 1997-07-01
HRP940315B1 (en) 2000-12-31
CO4230094A1 (es) 1995-10-19
US5741806A (en) 1998-04-21
SI0700290T1 (en) 1999-12-31
AU6970994A (en) 1994-12-20
EP0700290B1 (fr) 1999-08-25
CA2162919A1 (fr) 1994-12-08
WO1994027599A1 (fr) 1994-12-08
AU680918B2 (en) 1997-08-14
NO954783D0 (no) 1995-11-24
GB2279008A (en) 1994-12-21
CN1106194C (zh) 2003-04-23
PL311721A1 (en) 1996-03-04
SA94150003B1 (ar) 2005-04-11
EP0700290A1 (fr) 1996-03-13
HRP970315A2 (en) 1999-04-30
AP544A (en) 1996-10-11
BR1100046A (pt) 1999-11-23
IS1868B (is) 2003-05-02
HUT74867A (en) 1997-02-28
JPH08510457A (ja) 1996-11-05
IL109749A0 (en) 1994-08-26
SG48119A1 (en) 1998-04-17
IL109749A (en) 1999-03-12
DK0700290T3 (da) 2000-03-13
PL175578B1 (pl) 1999-01-29
CY2411B1 (en) 2004-11-12
IE80632B1 (en) 1998-10-21
NO306448B1 (no) 1999-11-08
HU227121B1 (en) 2010-07-28
GB2279008B (en) 1997-06-18
CN1124454A (zh) 1996-06-12
CA2162919C (fr) 1999-07-20
HU9503375D0 (en) 1996-01-29
IE940420A1 (en) 1994-11-30
AP9400643A0 (en) 1994-07-31
DE69420266D1 (de) 1999-09-30
GR3031669T3 (en) 2000-02-29
HRP940315A2 (en) 1996-08-31
DE69420266T2 (de) 1999-12-09
BE1007158A3 (fr) 1995-04-11
NZ267415A (en) 1997-10-24
GB9409835D0 (en) 1994-07-06
CZ308595A3 (en) 1996-06-12
MY111445A (en) 2000-05-31
IS4168A (is) 1994-11-26
CZ291041B6 (cs) 2002-12-11
ECSP941088A (es) 1994-11-16
JP2965703B2 (ja) 1999-10-18
ZA943593B (en) 1995-02-13
ITRM940322A1 (it) 1995-11-24
KR100297212B1 (ko) 2001-10-24
GB9310756D0 (en) 1993-07-14
ES2136198T3 (es) 1999-11-16
ATE183643T1 (de) 1999-09-15
RU2132684C1 (ru) 1999-07-10
FR2705569A1 (fr) 1994-12-02
NO954783L (no) 1995-11-24

Similar Documents

Publication Publication Date Title
FR2717250B1 (fr) Système d'injection à prémélange.
DZ1759A1 (fr) Produits pharmaceutiques à base d'acide nucleique.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FR2734483B1 (fr) Forme d'administration pharmaceutique comprenant de l'oxybutynine
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
DZ1835A1 (fr) Nouvelles formulations.
FR2696728B1 (fr) Plate-forme à déplacement vertical.
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2687910B1 (fr) Presentoir d'instrumentation dentaire.
IT1246445B (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
FR2714441B1 (fr) Dispositif d'actionnement à gradins.
FR2705569B1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
FR2676557B3 (fr) Boitier d'ordinateur.
FR2670936B1 (fr) Organe d'affichage fluorescent.
FR2720262B1 (fr) Dispositif d'ostéosynthèse à coapteurs rapportés.
DZ1965A1 (fr) Composition pharmaceutique nouvelle.
BR9612470A (pt) Medicamento à base de antigucocorticóide
FR2705895B1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.
FR2717692B1 (fr) Nouvelle composition médicamenteuse à base d'argile.
FR2719040B1 (fr) Nouveaux agents tensio-actifs à base d'éthers polyoxy-éthylénique-propylénique.
FR2721288B1 (fr) Silo d'homogénéisation.
FR2720936B1 (fr) Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique.
FR2706420B1 (fr) Présentoir d'outils à main.
IT1243894B (it) Disposizione di anello d'otturazione.